Navigation Links
Simple new test to combat counterfeit drug problem in developing countries
Date:8/19/2012

PHILADELPHIA, Aug. 19, 2012 In a thrust against the major problem of counterfeit medicines sold in developing countries, which causes thousands of illnesses and deaths annually, scientists today described development of a simple, paper-strip test that people could use to identify counterfeit versions of one of the most-frequently faked medicines in the world.

Their report on an inexpensive test to identify fake tablets of Panadol was presented here at the 244th National Meeting & Exposition of the American Chemical Society, the world's largest scientific society.

Panadol is one of multiple brand names used abroad for the pain-and-fever-reliever acetaminophen, most familiar in the U.S. as Tylenol. The scientists emphasized that no such problem exists with Tylenol or other acetaminophen products marketed in the U.S.

However, Toni L. O. Barstis, Ph.D., a chemistry professor and leader of the research team at Saint Mary's College in Notre Dame, Ind., said that ersatz Panadol and other counterfeit brand-name acetaminophen products are the tip of the iceberg in a wider problem of fake drugs sold in developing countries.

"Panadol long has been among the most common, standard pain-relieving drugs counterfeited around the world," Barstis said. "But the problem has taken on a troubling new dimension. In the past, you could just look at the labeling and packaging and know if it was counterfeit. Now, they do such a good job with the package design it's hard to determine whether it's a package of the genuine medicine or a fake that contains no acetaminophen or even ingredients that may be harmful."

The World Health Organization estimates that at least 10 percent of the drug supply in developing countries consists of counterfeit medicines, causing thousands of deaths every year. Problems have been documented, for instance, in Kenya, Nigeria, India, Vietnam and Panama. Many of the deaths occur among people who unknowingly take counterfeit antibiotics and anti-malaria medicines that do not contain the active ingredient to combat those diseases. In addition to lacking the active ingredient, counterfeit medicines may harm people by containing ingredients that are potentially toxic. Officials blame crime rings, which profit from selling at full-price pills that contain plaster of Paris, baking soda or other inexpensive ingredients.

Compounding the problem, Barstis explained, is the difficulty in testing medications for authenticity. In some instances, it may take 3-6 months to test a batch of suspect drugs because the testing is usually done in Europe or the U.S. Barstis' team responded to that situation with the new test for Panadol, which takes less than 10 minutes, can be done by consumers and also can be used by personnel in government regulatory agencies, clinics and hospitals.

The test consists of chemically treated paper the size of a business card. To check for counterfeit ingredients, a person simply swipes the pill over the paper and dips the paper in water. Color changes on the paper indicate suspicious ingredients. Barstis validated the test on 570 pills, including many with fake ingredients added by researchers. The College has applied for a patent for the test.

Barstis' team now is developing a similar test to identify counterfeit antibiotics, anti-malaria drugs, and Tamiflu, the influenza medication. The team works in collaboration with chemistry, biochemistry, computer science and industrial design teams at the University of Notre Dame, Ind.


'/>"/>

Contact: Michael Bernstein
m_bernstein@acs.org
215-418-2056 (Philadelphia Press Center, Aug. 17-23)
202-872-6042

Michael Woods
m_woods@acs.org
215-418-2056 (Philadelphia Press Center, Aug. 17-23)
202-872-6293
American Chemical Society


Source:Eurekalert

Related medicine news :

1. Simple mathematical computations underlie brain circuits
2. Simple Measures May Curb Excessive Weight Gain in Pregnancy
3. Simple Steps Can Shield Children From Dog Bites
4. Simple exercises are an easy and cost-effective treatment for persistent dizziness
5. Simpler lifestyle found to reduce exposure to endocrine-disrupting chemicals
6. Simple new way to clean traces of impurities from drug ingredients
7. Safe, simple eye test may help save lives by preventing stroke
8. Cancer may require simpler genetic mutations than previously thought
9. Prosthetic retina offers simple solution to restoring sight
10. Simple assault and ground level fall do not require cervical spine CT
11. New technology combats global pandemic of drug counterfeiting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... Splashtop Inc. ... Pro . This new addition to the Mirroring360 product family combines device screen ... , Mirroring360 Pro enables educators, business professionals and individuals to stream or mirror ...
(Date:4/25/2017)... ... 2017 , ... As President Trump challenges the status quo ... administration could impact the employee benefits industry. James Slotnick, AVP, Government Relations, for ... make it through Congress. His discussion will focus on the current state of ...
(Date:4/25/2017)... ... 25, 2017 , ... Patients who would like to straighten ... fraction of the time as traditional braces – Wilckodontics®. Dr. Victoria Chen, an ... this revolutionary treatment with or without a referral. , Wilckodontics is also ...
(Date:4/25/2017)... ... ... Buyers and sellers in the thriving multi-billion dollar cannabis marketplace – from medical ... heartened by the industry’s current surge. But another thing that unifies them is a ... last they can simply, safely and effectively end their aroma anguish thanks to a ...
(Date:4/25/2017)... ... April 25, 2017 , ... There is no better place in South ... special report in the May issue of Consumer Reports focused on heart health. ... results achieved during and after coronary bypass and aortic valve replacement procedures. , ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Research and Markets has announced the addition ... Addressing Production Complexities Through Risk Management and Quality by ... ... Market Prospects: Overcoming Production Complexities Through Risk Management and ... current trends in the global biosimilars market, with a ...
(Date:4/20/2017)... , April 20, 2017  AbbVie (NYSE: ABBV), ... percent (n=145/146) of chronic hepatitis C virus (HCV) ... or 6 and compensated cirrhosis (Child-Pugh A) achieved ... 12 ) with its investigational, pan-genotypic regimen of ... were seen following 12 weeks of G/P treatment ...
(Date:4/19/2017)... CRH) (NYSE MKT: CRHM) (the "Company"), announces that it will participate ... the Sheraton Hotel in Toronto, Ontario . ... is scheduled to present on Tuesday, May 2 at 10:00 am. ... the Board, Tony Holler will also attend the event. ... For more details about the ...
Breaking Medicine Technology: